Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IIINASDAQ:MXCTNASDAQ:OABIOTCMKTS:TGLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIIIInformation Services Group$5.00-2.2%$4.63$2.95▼$5.18$246.32M1.21121,227 shs453,492 shsMXCTMaxCyte$2.17-2.7%$2.31$2.00▼$5.20$237.84M1.23615,909 shs615,660 shsOABIOmniAb$1.87-3.1%$1.58$1.22▼$4.96$235.72M0.14649,678 shs718,374 shsTGLOtheglobe.com$0.17+19.3%$0.23$0.07▼$0.73$61.81M-1.3850,866 shs106,900 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIIIInformation Services Group0.00%+8.17%+4.36%+37.06%+68.23%MXCTMaxCyte0.00%+1.59%+3.95%-9.51%-39.27%OABIOmniAb0.00%+14.41%+29.67%-6.94%-49.08%TGLOtheglobe.com0.00%-29.89%-48.03%-48.15%-12.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIIIInformation Services Group2.3257 of 5 stars1.53.01.70.01.92.51.9MXCTMaxCyte2.0272 of 5 stars3.53.00.00.00.01.70.6OABIOmniAb2.5799 of 5 stars3.51.00.00.00.83.31.3TGLOtheglobe.comN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIIIInformation Services Group 3.00Buy$5.5010.00% UpsideMXCTMaxCyte 3.00Buy$7.50245.62% UpsideOABIOmniAb 3.00Buy$7.00274.33% UpsideTGLOtheglobe.com 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TGLO, III, MXCT, and OABI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025IIIInformation Services GroupSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/12/2025IIIInformation Services GroupBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$3.75 ➝ $5.505/12/2025OABIOmniAbBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIIIInformation Services Group$247.59M0.97$0.22 per share22.54$1.96 per share2.55MXCTMaxCyte$38.63M5.98N/AN/A$1.95 per share1.11OABIOmniAb$26.74M8.54N/AN/A$2.37 per share0.79TGLOtheglobe.comN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIIIInformation Services Group$2.84M$0.1533.3331.251.473.18%7.10%3.13%8/4/2025 (Estimated)MXCTMaxCyte-$41.06M-$0.40N/AN/AN/A-110.92%-19.90%-17.24%8/5/2025 (Estimated)OABIOmniAb-$62.03M-$0.58N/AN/AN/A-229.11%-21.37%-18.84%8/6/2025 (Estimated)TGLOtheglobe.com-$200KN/A0.00∞N/AN/AN/A-1,256.70%N/ALatest TGLO, III, MXCT, and OABI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025IIIInformation Services Group$0.07N/AN/AN/A$59.98 millionN/A5/8/2025Q1 2025OABIOmniAb-$0.17-$0.17N/A-$0.17$4.49 million$4.15 million5/7/2025Q1 2025MXCTMaxCyte-$0.10-$0.10N/A-$0.10$9.05 million$10.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIIIInformation Services Group$0.183.60%N/A120.00%1 YearsMXCTMaxCyteN/AN/AN/AN/AN/AOABIOmniAbN/AN/AN/AN/AN/ATGLOtheglobe.comN/AN/AN/AN/AN/ALatest TGLO, III, MXCT, and OABI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025IIIInformation Services Groupquarterly$0.04503.9%6/6/20256/6/20256/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIIIInformation Services Group0.622.422.42MXCTMaxCyteN/A12.2311.58OABIOmniAbN/A4.704.70TGLOtheglobe.comN/A0.010.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIIIInformation Services Group73.10%MXCTMaxCyte68.81%OABIOmniAb72.08%TGLOtheglobe.comN/AInsider OwnershipCompanyInsider OwnershipIIIInformation Services Group15.90%MXCTMaxCyte3.30%OABIOmniAb8.60%TGLOtheglobe.com72.26%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIIIInformation Services Group1,32348.20 million40.54 millionNot OptionableMXCTMaxCyte80106.42 million102.90 millionOptionableOABIOmniAb7122.14 million111.63 millionOptionableTGLOtheglobe.comN/A441.48 million122.47 millionNot OptionableTGLO, III, MXCT, and OABI HeadlinesRecent News About These Companiestheglobe.com (OTCMKTS:TGLO) Trading Down 29.6% - Here's WhyJuly 6 at 4:59 AM | americanbankingnews.comtheglobe.com (OTCMKTS:TGLO) Trading Down 29.6% - Should You Sell?July 4 at 12:44 AM | marketbeat.comtheglobe.com (OTCMKTS:TGLO) Stock Price Down 10% - Here's What HappenedJune 13, 2025 | marketbeat.com📺 + 📰 The Globe and 12 News have a new partnershipNovember 8, 2024 | bostonglobe.comBGetting people back on the TOctober 29, 2024 | bostonglobe.comBTGLO theglobe.com, inc.October 26, 2024 | seekingalpha.comAP Top 25: No. 5 Tennessee continues to climb, Missouri slips to 11th despite winSeptember 24, 2024 | joplinglobe.comJCIA spy 'supposed to protect the world from evil' abused women across the globeSeptember 21, 2024 | news.sky.comNHow the Globe is covering climate changeSeptember 19, 2024 | bostonglobe.comBToday's Globle Answers & HintsSeptember 18, 2024 | gamerant.comGStarting PointSeptember 9, 2024 | bostonglobe.comBNBA NewsAugust 30, 2024 | thescore.comTA joyful yet bittersweet end to summer at TanglewoodAugust 27, 2024 | bostonglobe.comBIntroducing Boston Globe TodayAugust 25, 2024 | bostonglobe.comBTV content change coming to Globe in Aug. 21 editionAugust 16, 2024 | dglobe.comDTralliance Corporation and EXPOTUR Announce Partnership With the Launch of EXPOTUR.TRAVELAugust 15, 2024 | br.advfn.comPresident and CEO of Tralliance Corporation to Address EXPOTUR 2008 in San Jose, Costa RicaAugust 15, 2024 | br.advfn.comGBH lays off 31 employees, suspends production of 3 TV showsMay 23, 2024 | msn.comWebXtra: Kilgore College professor details globe-trotting life fueled by geology studiesMay 16, 2024 | msn.comThe GlobeMay 6, 2024 | londonist.comLThe Complete Walk celebrates 'exotic' ShakespeareApril 30, 2024 | bbc.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTGLO, III, MXCT, and OABI Company DescriptionsInformation Services Group NASDAQ:III$5.00 -0.11 (-2.15%) Closing price 04:00 PM EasternExtended Trading$5.12 +0.12 (+2.40%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX to automate the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management; ISG Generative AI; ISG Network Select to streamline and simplify how enterprises build their network solutions; HR technology and transformations; providers-as-a-business services; ISG Digital Engineering; ISG Research; and training-as-a-service. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.MaxCyte NASDAQ:MXCT$2.17 -0.06 (-2.69%) Closing price 04:00 PM EasternExtended Trading$2.20 +0.04 (+1.61%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.OmniAb NASDAQ:OABI$1.87 -0.06 (-3.11%) Closing price 04:00 PM EasternExtended Trading$1.88 +0.01 (+0.80%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.theglobe.com OTCMKTS:TGLO$0.17 +0.03 (+19.29%) As of 03:52 PM Easterntheglobe.com, inc. does not have significant operations. Previously, it was involved in the operation of an online community with registered members and users in the United States and internationally. The company was incorporated in 1995 and is based in Houston, Texas. theglobe.com, inc. is a subsidiary of Delfin Midstream LLC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
